![Niels Johansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Niels Johansen
Plus aucun poste en cours
Profil
Niels Johansen has held positions as a Board Member & Director-Invitro Diagnostics at ALK-Abello A, Director at Medical Prognosis Institute A, and Director at Allarity Therapeutics A.
Anciens postes connus de Niels Johansen
Sociétés | Poste | Fin |
---|---|---|
Allarity Therapeutics A/S
![]() Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Directeur/Membre du Conseil | 18/12/2018 |
ALK-ABELLÓ A/S | Directeur/Membre du Conseil | - |
Medical Prognosis Institute A/S
![]() Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ALK-ABELLÓ A/S | Health Technology |
Entreprise privées | 2 |
---|---|
Medical Prognosis Institute A/S
![]() Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Health Technology |
Allarity Therapeutics A/S
![]() Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |